Back

CME Outfitters, LLC

  • Diabetes Mellitus, Type 2
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Non-alcoholic Fatty Liver Disease
  • Obesity
  • Renal Insufficiency, Chronic

GLP-1 RA Myths & Realities: Navigating Safety and Tolerability

GLP-1 receptor agonists (GLP-1 RAs) have redefined the standard of care for type 2 diabetes (T2D), especially in patients with cardiovascular disease (CVD), chronic kidney disease (CKD), obesity, or metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis (MASLD/MASH). These innovative therapies offer proven, multi-organ benefits that go far beyond glucose control. Despite their powerful potential, concerns around safety, tolerability, and side effects persist that lead to hesitation, underutilization, or premature therapy discontinuation. Misconceptions around who should receive GLP-1 RAs, how to stratify risk, or how to optimize dosing strategies remain barriers to care. Clinicians and multidisciplinary care teams need targeted education that demystifies the safety profile of GLP-1 RAs and builds confidence for effective, patient-centered counseling so that patients with T2D can reap the full rewards of these life-changing therapies. In the fifth activity of this CME Outfitters Snack series, expert faculty will assess dosing strategies and escalation best practices to optimize patient outcomes and foster therapy adherence. Faculty will model development of patient-centered counseling strategies that address concerns or misconceptions of GLP-1 RA therapies, including evidence-based benefits.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Sep 26, 2025
  • Last day to claim credit
    Nov 11, 2026 4 weeks left